MedTrace Logo

General Practitioner (GP) Practice Based Pharmacist Input to Medicines Optimisation

NCT03241498 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 356

Last updated 2019-12-17

No results posted yet for this study

Summary

The study is a United Kingdom (UK) based multi-centre study which will evaluate the impact of a medication optimisation intervention (delivered in GP practices by pharmacists to patients at risk of medication related problems), on healthcare resource utilisation and patient outcomes. Pharmacists in 4 areas across the UK (3 in England and 1 in Northern Ireland) will engage with patients, thought to be at a higher risk of medication related problems, within their GP practice in order to help identify areas for improvement

Conditions

  • Medication Adherence

Interventions

OTHER

Medicines optimisation

Sponsors & Collaborators

  • Medicines Optimisation Innovation Centre (MOIC)

    collaborator UNKNOWN

  • Association of the British Pharmaceutical Industry (ABPI)

    collaborator UNKNOWN

  • Queen's University, Belfast

    lead OTHER

Principal Investigators

  • James C McElnay, PhD · Queen's University, Belfast

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-12-01
Primary Completion
2018-03-31
Completion
2019-05-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03241498 on ClinicalTrials.gov